Overview
Turja Chakrabarti is a primary care provider, practicing in Internal Medicine in San Francisco, California.
His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Primary Lymphoma of the Brain.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
505 Parnassus Ave, San Francisco, CA 94143
1500 Duarte Rd, Duarte, CA 91010
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Anesthesia Medical Group
Dr. Carolyn S. Calfee is a pulmonologist who cares for patients in UCSF's intensive care units. Calfee's research focuses on the causes and treatment of acute respiratory distress syndrome (ARDS). Her projects include studying the biologic differences within ARDS and how to target those differences by personalizing treatment; the role of environmental exposure, including to cigarette smoke and air pollution, in susceptibility to lung injury; and novel treatments for ARDS. During the coronavirus pandemic, she led research at UCSF to investigate how the immune system responds to COVID and to test promising new treatments for COVID-19-associated ARDS. Calfee earned her medical degree from the University of Pennsylvania Perelman School of Medicine. At UCSF, she completed a residency in internal medicine, serving as chief resident, followed by a fellowship in pulmonary and critical care medicine. She also earned a master of advanced study degree in clinical research at UCSF. She joined the UCSF faculty in 2007 and is a member of the UCSF Center for Tobacco Control Research and Education. Dr. Calfee is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Sepsis, Pulmonary Edema, COVID-19, and Lung Transplant. Dr. Calfee is board certified in American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease and American Board Of Internal Medicine, Critical Care Medicine. Dr. Calfee is currently accepting new patients.
Office
Michael Levy is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Levy is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Neuromyelitis Optica, Hereditary Pancreatitis, Gastric Lymphoma, Endoscopy, and Gallbladder Removal.
Liver Tumor Clinic
Marion Peters is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Peters is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Hepatitis, Hepatitis C, Non-Alcoholic Fatty Liver Disease, Hepatitis B, and Liver Transplant.
Frequently Asked Questions about Dr. Turja Chakrabarti
How do I make an appointment with Dr. Turja Chakrabarti?
You can book an appointment with Dr. Turja Chakrabarti by calling their office at 410-550-3350. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Turja Chakrabarti a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Turja Chakrabarti is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Turja Chakrabarti specialize in?
While Dr. Turja Chakrabarti is a Internal Medicine, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Turja Chakrabarti participate in research or clinical trials?
Yes. Dr. Turja Chakrabarti has published 8 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Turja Chakrabarti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Turja Chakrabarti accept my insurance?
Dr. Turja Chakrabarti accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-550-3350 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Chakrabarti isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- EGFR Positive Lung CancerDr. Chakrabarti isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Immunoblastic LymphomaDr. Chakrabarti isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Lung AdenocarcinomaDr. Chakrabarti isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Chakrabarti isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Chakrabarti isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Primary Lymphoma of the BrainDr. Chakrabarti isExperienced. Learn about Primary Lymphoma of the Brain.
- Sudden Infant Death Syndrome (SIDS)Dr. Chakrabarti isExperienced. Learn about Sudden Infant Death Syndrome (SIDS).